Page last updated: 2024-09-05

f 1394 and Hyperlipemia

f 1394 has been researched along with Hyperlipemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Voogd, NJ; Eguchi, K; Fujiwara, Y; Hayashida, A; Horlad, H; Kato, H; Losung, F; Mangindaan, RE; Rotinsulu, H; Takeya, M; Tsukamoto, S1
Aragane, K; Kitamine, T; Kusunoki, J; Ohnishi, H; Yamaura, T2
Aragane, K; Chiwata, T; Fujinami, K; Kano, K; Kitamine, T; Kojima, K; Kozono, H; Kusunoki, J; Sekine, Y1
Horiuchi, S; Miyazaki, A1

Reviews

1 review(s) available for f 1394 and Hyperlipemia

ArticleYear
[ACAT inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Anilides; Animals; Arteriosclerosis; Benzofurans; Cholesterol Esters; Cyclohexanes; Dioxanes; Endothelium, Vascular; Humans; Hyperlipidemias; Imidazoles; Intestine, Small; Liver; Organ Specificity; Phenylurea Compounds; Sterol O-Acyltransferase; Urea

2001

Other Studies

4 other study(ies) available for f 1394 and Hyperlipemia

ArticleYear
Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo.
    Bioorganic & medicinal chemistry, 2013, Jul-01, Volume: 21, Issue:13

    Topics: Alkaloids; Animals; Atherosclerosis; Carbazoles; Cells, Cultured; CHO Cells; Cholesterol; Cholesterol Esters; Cricetinae; Cricetulus; Foam Cells; Humans; Hyperlipidemias; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Porifera; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2

2013
[Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1997, Volume: 117, Issue:4

    Topics: Animals; Cholesterol; Cyclohexanes; Depression, Chemical; Dietary Fats; Dioxanes; Dogs; Dose-Response Relationship, Drug; Hyperlipidemias; Male; Sterol O-Acyltransferase; Triglycerides

1997
Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein se
    Japanese journal of pharmacology, 1998, Volume: 76, Issue:3

    Topics: Animals; Anticholesteremic Agents; Cell Line; Cyclohexanes; Dioxanes; Enzyme Inhibitors; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins, VLDL; Liver; Polyethylene Glycols; Rats; Sterol O-Acyltransferase

1998
Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:1

    Topics: Animals; Cholesterol; Cyclohexanes; Diabetes Mellitus, Experimental; Dietary Fats; Dioxanes; Disease Models, Animal; Eating; Enzyme Inhibitors; Hyperlipidemias; Intestine, Small; Lymphatic System; Male; Rats; Rats, Sprague-Dawley; Risk Factors; Sterol O-Acyltransferase; Triglycerides

2000